Dudediligence.

Dyadic International, Inc

DYAINASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$2.0MSep ’24$817,376Dec ’24$393,572Mar ’25$966,630Jun ’25$1.2MSep ’25$565,526Dec ’25$1.1MMar ’26$961,138Jun ’26
Net income, by quarter
−$203,460Sep ’24−$1.6MDec ’24−$2.0MMar ’25−$1.8MJun ’25−$2.0MSep ’25−$1.6MDec ’25−$2.0MMar ’26−$2.1MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$2.4M$2.9M$2.9M$3.5M$3.1M
Gross profit$459,393$807,110$922,957$2.3M$770,485
Operating income−$14.7M−$10.2M−$8.2M−$5.9M−$7.2M
Net income−$13.1M−$9.7M−$6.8M−$5.8M−$7.4M
Operating cash flow−$11.3M−$8.1M−$6.7M−$4.0M−$5.7M
Cash$15.7M$5.8M$6.5M$6.5M$4.6M
Shares outstanding28.2M28.6M28.8M29.8M36.2M